Glutathione reduced ethyl ester

CAS : 118421-50-4

Ref. 3D-FG03344

Informations sur le produit

• Nom: Glutathione reduced ethyl ester
• Synonymes: GSH-MEE Glutathione Monoethyl Ester gamma-Glu-Cys-Gly-OEt, Glutathione monoethyl ester, Glycine, <span class="text-smallcaps">L</smallcap>-γ-glutamyl-<smallcap>L</span>-cysteinyl-, monoethyl ester, Glycine, N-(N-<span class="text-smallcaps">L</smallcap>-γ-glutamyl-<smallcap>L</span>-cysteinyl)-, monoethyl ester, Glycine, N-(N-L-gamma-glutamyl-L-cysteinyl)-, monoethyl ester, Ione Ethyl Ester, N-(N-L-gamma-Glutamyl-L-cysteinyl)glycine monoethyl ester, ethyl L-gamma-glutamyl-L-cysteinylglycinate, Glycine, N-(N-L-γ-glutamyl-L-cysteinyl)-, monoethyl ester, Glycine, L-γ-glutamyl-L-cysteinyl-, monoethyl ester

Description

Glutathione reduced ethyl ester (GR-E) is a potential anticancer drug that binds to the DNA and induces reactive oxygen species. GR-E has been shown to have minimal toxicity in vivo, with no observable adverse effects on the liver. GR-E has also been shown to be effective in treating squamous cell carcinoma cells by binding to their DNA and inducing apoptosis. This drug had minimal toxicity in animal studies, with no observable adverse effects on the liver. GR-E has been shown to be effective in treating squamous cell carcinoma cells by binding to their DNA and inducing apoptosis. This drug had minimal toxicity in animal studies, with no observable adverse effects on the liver. GR-E has also been shown to bind to toll-like receptor 2, which may lead to an antiinflammatory response.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 443.47 g/mol
• Formule: C₁₂H₂₁N₃O₆S
• Degré de pureté: Min. 90 Area-%
• Couleur/Forme: Powder